This episode covers:&nbsp;• Longevity Influence&nbsp;In&nbsp;The&nbsp;Epstein Files&nbsp;A new DOJ document release tied to the Epstein investigation pulled physician and longevity influencer Peter Attia into the spotlight, after reports showed he appeared in the files more than 1,800 times and CBS News pulled a planned rebroadcast of its 60 Minutes profile. Dave breaks down why this story matters beyond headlines: longevity relies heavily on trust, authority, and influence, and when those foundations are&nbsp;shaken&nbsp;it exposes how fragile centralized&nbsp;expertise&nbsp;can be. He explains how biohackers can protect themselves by diversifying information sources, understanding mechanisms instead of personalities, and building health strategies that&nbsp;don’t&nbsp;collapse when one voice disappears.&nbsp;•&nbsp;Source:&nbsp;<a href="https://variety.com/2026/tv/news/cbs-news-pulls-peter-attia-60-minutes-segment-epstein-1236650930/" rel="noopener noreferrer" target="_blank">https://variety.com/2026/tv/news/cbs-news-pulls-peter-attia-60-minutes-segment-epstein-1236650930/</a>&nbsp;• Age-Reversal Gene Therapy Enters Human Trials&nbsp;Life Biosciences received FDA authorization to begin the first U.S. human trial of a partial epigenetic reprogramming gene therapy in the eye, using three Yamanaka factors to restore function in damaged retinal cells. Dave explains why eyes are the ideal first testing ground, what partial reprogramming&nbsp;actually means, and why this marks a shift from longevity theory into real clinical testing. He also clarifies what success would and would not mean for whole-body rejuvenation, and how to separate legitimate gene-therapy advances from consumer products that only claim to affect biological age.&nbsp;•&nbsp;Source:&nbsp;<a href="https://fortune.com/2026/01/30/billionaires-longevity-aging-fda-human-clinical-trial-life-biosciences/" rel="noopener noreferrer" target="_blank">https://fortune.com/2026/01/30/billionaires-longevity-aging-fda-human-clinical-trial-life-biosciences/</a>&nbsp;• Continuous Ketone Monitoring Moves Toward Reality&nbsp;Wearable continuous ketone monitoring is advancing beyond finger-stick meters, with companies adapting the same model that made continuous glucose monitors mainstream. Dave explains why this is a major upgrade for metabolic flexibility, keto diets, fasting, and diabetes risk management. He breaks down how real-time ketone data can reveal patterns missed by spot checks, and why biohackers should think ahead about data ownership, integration, and how ketone signals interact with glucose, sleep, stress, and training.&nbsp;•&nbsp;Source:&nbsp;<a href="https://finance.yahoo.com/news/global-market-blood-ketone-meters-140900796.html" rel="noopener noreferrer" target="_blank">https://finance.yahoo.com/news/global-market-blood-ketone-meters-140900796.html</a>&nbsp;• Injectable, Wireless Brain Implants Without Surgery&nbsp;Researchers are developing&nbsp;nano-scale, wireless brain implants capable of crossing the blood-brain barrier without open surgery, opening the door to a new class of neural interfaces. Dave connects this research to other circuit-level interventions like sound and light stimulation, explaining the broader shift from targeting molecules to tuning brain networks. He also addresses the ethical risks, including consent, privacy, and neuro-surveillance, and why biohackers should track this space early rather than after it becomes normalized.&nbsp;•&nbsp;Source:&nbsp;<a href="https://longevity.technology/unlocked/longevity-news-roundup-week-5-2026/" rel="noopener noreferrer" target="_blank">https://longevity.technology/unlocked/longevity-news-roundup-week-5-2026/</a>&nbsp;• Generic GLP-1 Drugs Could Reshape Global Metabolic Health&nbsp;India’s Sun Pharma is preparing to launch a generic semaglutide-style injectable as patent protections expire, signaling a major price drop and access expansion for GLP-1 drugs. Dave explains why this could transform obesity, diabetes, and cardiovascular disease management worldwide, while also highlighting the risks of muscle loss and metabolic weakness if these drugs are used without proper training and nutrition. He shares how biohackers should think about stacking GLP-1s intelligently, with resistance training, protein intake, and long-term maintenance strategies.&nbsp;•&nbsp;Source:&nbsp;<a href="https://longevity.technology/unlocked/longevity-news-roundup-week-5-2026/" rel="noopener noreferrer" target="_blank">https://longevity.technology/unlocked/longevity-news-roundup-week-5-2026/</a>&nbsp;All source links are provided for direct access to the original reporting and research.&nbsp;This episode is designed for biohackers, longevity seekers, and high-performance listeners who want clear thinking in a noisy health landscape. Host Dave Asprey connects ethics, emerging science, metabolic data, neurotechnology, and drug access into practical lessons for building a resilient, adaptable health strategy that works even as trends and narratives change.&nbsp;New episodes every Tuesday, Thursday, Friday, and Sunday.&nbsp;Keywords:&nbsp;longevity influencer ethics, Peter Attia Epstein files, trust in longevity science, epigenetic reprogramming gene therapy, Yamanaka factors OSK, age reversal human trials, Life Biosciences FDA trial, continuous ketone monitoring, CKM metabolic tracking, glucose ketone wearable sensors, Abbott Libre ketone sensor, metabolic flexibility biohacking, wireless brain implants, blood brain barrier neurotech, cognitive longevity technology, GLP-1 generic semaglutide, Sun Pharma GLP-1, GLP-1 muscle loss prevention, resistance training longevity, metabolic health upgrades, biohacking&nbsp;&nbsp;Thank you to our sponsors!&nbsp;&nbsp;-&nbsp;GOT MOLD? | Go to&nbsp;<a href="http://gotmold.com/shop" rel="noopener noreferrer" target="_blank">http://gotmold.com/shop</a>&nbsp;and use DAVE10 to save 10% and see what’s in your air.-&nbsp;Essentia | Go to&nbsp;<a href="https://myessentia.com/dave" rel="noopener noreferrer" target="_blank">https://myessentia.com/dave</a>&nbsp;and use code DAVE for $100 off The Dave Asprey Upgrade.Resources:&nbsp;&nbsp;• Subscribe to my weekly newsletter:&nbsp;<a href="https://substack.daveasprey.com/welcome" rel="noopener noreferrer" target="_blank">https://substack.daveasprey.com/welcome</a>&nbsp;• Danger Coffee:&nbsp;<a href="https://dangercoffee.com/discount/dave15" rel="noopener noreferrer" target="_blank">https://dangercoffee.com/discount/dave15</a>&nbsp;&nbsp;• My Daily Supplements:&nbsp;<a href="https://www.shopsuppgradelabs.com/discount/DAVE15" rel="noopener noreferrer" target="_blank">SuppGrade Labs</a>&nbsp;(15% Off)&nbsp;&nbsp;• Favorite Blue Light Blocking Glasses:&nbsp;<a href="https://truedark.com/?coupon-code=DAVEASPREY15&sc-page=shop" rel="noopener noreferrer" target="_blank">TrueDark</a>&nbsp;(15% Off)&nbsp;&nbsp;• Dave Asprey’s BEYOND Conference:&nbsp;<a href="https://beyondconference.com/" rel="noopener noreferrer" target="_blank">https://beyondconference.com</a>&nbsp;&nbsp;• Dave Asprey’s New Book –&nbsp;Heavily Meditated:&nbsp;<a href="https://daveasprey.com/heavily-meditated" rel="noopener noreferrer" target="_blank">https://daveasprey.com/heavily-meditated</a>&nbsp;• Upgrade Collective:&nbsp;<a href="https://www.ourupgradecollective.com/" rel="noopener noreferrer" target="_blank">https://www.ourupgradecollective.com</a>&nbsp;&nbsp;• Upgrade Labs:&nbsp;<a href="https://upgradelabs.com/" rel="noopener noreferrer" target="_blank">https://upgradelabs.com</a>&nbsp;&nbsp;• 40 Years of Zen:&nbsp;<a href="https://40yearsofzen.com/" rel="noopener noreferrer" target="_blank">https://40yearsofzen.com</a>&nbsp;Timestamps:&nbsp;0:00&nbsp;- Intro&nbsp;0:18&nbsp;- Story 1: Attia Epstein Controversy&nbsp;1:34&nbsp;- Story 2: Life Biosciences Gene Therapy Trial&nbsp;2:44&nbsp;- Story 3: Continuous Ketone Monitoring&nbsp;3:50&nbsp;- Story 4: Wireless Brain Implants&nbsp;4:53&nbsp;- Story 5: Generic GLP-1 Drugs&nbsp;6:00&nbsp;- Closing Thoughts&nbsp;See Privacy Policy at <a href="https://art19.com/privacy" rel="noopener noreferrer" target="_blank">https://art19.com/privacy</a> and California Privacy Notice at <a href="https://art19.com/privacy#do-not-sell-my-info" rel="noopener noreferrer" target="_blank">https://art19.com/privacy#do-not-sell-my-info</a>.

Podurama

Home

Trending

Personal

Your Podcasts

New Episodes

My Files

Favourite Episodes

Tags (Folders)

Recently Played

Bookmarks

Followed Playlists

Biohackers in the Epstein Files, Generic GLP-1s, Continuous Ketone Monitors, and more... : 1411

The Human Upgrade: Biohacking for Longevity & Performance

AI Chapters

AI Insights

Reviews